Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients - Wikidata - awgldk - TriplyDB

Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients

Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients

http://www.wikidata.org/entity/Q28397434

about

Epoxyeicosatrienoic acids and cardioprotection: the road to translation The role of epoxyeicosatrienoic acids in the cardiovascular system Vascular actions of 20-HETE A 3'-UTR Polymorphism in Soluble Epoxide Hydrolase Gene Is Associated with Acute Rejection in Renal Transplant Recipients Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study Aberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis model Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.20-HETE and CYP4A2 ω-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats.20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension 20-Hydroxyeicosatetraenoic Acid (20-HETE) Modulates Canonical Transient Receptor Potential-6 (TRPC6) Channels in Podocytes Oxidized fatty acid analysis by charge-switch derivatization, selected reaction monitoring, and accurate mass quantitation.Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1.The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins.Modulation of cardiac cytochrome P450 in patients with heart failure.Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease.Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes-A Link in the Onset and Development of Cardiovascular Disease?The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation.A Novel Polymorphism in the Promoter of the CYP4A11 Gene Is Associated with Susceptibility to Coronary Artery Disease.

P2860

Q28241262-CC022FDB-D73E-4FBD-A418-4548807B9290 Q28256560-429980D0-216C-46E9-8A42-CA88199658AF Q28259468-7C42D95E-4D48-439C-B5DE-EFE2E293D1D5 Q28384776-8D9A12B8-381E-4485-B053-6D31D8BBF9F2 Q28397330-88FB923B-9C16-4E09-8662-2233384C91E0 Q28397805-DB7D05CC-DA17-4206-89BE-0D648A46BF69 Q33775129-DC9C3C7D-E83A-4105-ADFB-6F5C3934095A Q34332185-564219A4-A818-4661-AB3D-6C23FA37166F Q37139461-D930A872-B69A-4F7B-876F-AEF15BECEFD5 Q37142503-E0F210D9-EB98-429B-9690-7C871C1B533B Q37218316-1519F590-686F-49B4-9E7E-186FB8CA4EED Q37296539-470551B9-FB49-4C06-BBD8-B68F17D97BF2 Q37340856-961C3B2D-08C3-41C6-8FE4-DE6611C26728 Q37403729-A0CEE99E-B79E-452F-93F8-2FA9A4C56791 Q37418399-8AE61688-14D9-4EC0-8962-032BEEEB0A61 Q38175461-CB9546F9-487D-406B-BE4C-BA4BDABC6300 Q41648482-A37CE9CA-9138-41E1-97AC-B07A7B6A5FEB Q47385143-3F383BA3-E778-4812-8D7C-F85B063A4570 Q47387223-04045001-833F-409B-B7C3-E16ABC995C9B Q47663532-6B16AB20-E767-45A1-B72E-DAEB57A23C6E Q48172048-CAEDE4B6-8D89-4260-A62A-8738A4254B17 Q51150942-AC67A8D8-22C9-4218-ACA1-069BCC8C664D

P2860

Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients

http://www.wikidata.org/entity/Q28397434

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cytochrome P450-derived eicosa ...... ronary artery disease patients

@ast

Cytochrome P450-derived eicosa ...... ronary artery disease patients

@en

Cytochrome P450-derived eicosa ...... ronary artery disease patients

@nl

type

label

Cytochrome P450-derived eicosa ...... ronary artery disease patients

@ast

Cytochrome P450-derived eicosa ...... ronary artery disease patients

@en

Cytochrome P450-derived eicosa ...... ronary artery disease patients

@nl

prefLabel

Cytochrome P450-derived eicosa ...... ronary artery disease patients

@ast

Cytochrome P450-derived eicosa ...... ronary artery disease patients

@en

Cytochrome P450-derived eicosa ...... ronary artery disease patients

@nl

P1433

Q28397434-6766D867-1896-4A2E-AF0B-9FF218166C5B

P1476

Q28397434-1D46D52A-DE69-4D1D-BAF5-DEAF643E42C9

P2093

Q28397434-009A38CC-8A36-4D98-B23D-984B72285635

Q28397434-266967FB-F515-4D57-A8AF-4D03E8F1CEB0

Q28397434-2873615E-16DC-4BC9-A7BA-C89087A5869D

Q28397434-439B0B92-B5A6-491C-9DAC-E0B32C646F08

Q28397434-7D019139-BA29-4796-8A6C-F023E7E09FC0

Q28397434-8F5037F5-939A-4F5A-9821-62B3A9B23AD4

Q28397434-A331DDE5-1CD8-4141-AC59-67C4BD7F0C0A

Q28397434-A339780B-4A29-4D17-A0AF-55938FBD087C

Q28397434-CA322CB3-E8F8-4632-89C3-6A7E8196AE23

Q28397434-EA920350-9E84-48C6-9707-B821415F6F3E

P2860

Q28397434-0719364F-2458-4846-8056-57B532F891A9

Q28397434-13DA6EDB-864F-44DB-903C-E8AA7FD27963

Q28397434-1A2ADC0A-E7C8-4B01-9B0F-7EED320C6FB2

Q28397434-3A6A9BD4-D60A-4A17-8B87-C3AD73E505D3

Q28397434-41615D57-E00B-490F-9391-F7F2CBF230C5

Q28397434-4D968BEB-002E-4B54-BB54-696AF24F8DA7

Q28397434-546A02C7-B451-4590-B6FA-F6C99212EAE2

Q28397434-54C7FCC1-9097-4C7B-AFDD-5628982E4AA6

Q28397434-6C3FECCA-C7BA-4C5C-8CBA-E990F90C39F3

Q28397434-73753C2E-CB0C-45F0-B33B-F73CC317A75A

P304

Q28397434-9746D6C0-7E76-43D3-AEAE-A0749B9BDE6D

P31

Q28397434-21A9F556-1148-400F-B8B3-E4C446B983A9

P3181

Q28397434-4A343134-55B3-493E-9F90-2BD10525F611

P356

Q28397434-1BC7F948-5E33-415A-A9FF-D2100D06B84B

P407

Q28397434-80DAFC7D-DE3D-4BE3-BFC0-B925A0A00010

P433

Q28397434-5E736403-E04F-4E80-9D94-C52BB85FDDBC

P478

Q28397434-267181F2-2E66-4F73-894E-D5B661941EF9

P50

Q28397434-34A8BE71-B1E5-43FD-A745-F6DB790E69BC

Q28397434-356F3A06-C211-4EF6-A20A-FE19F3F741DF

Q28397434-83126463-4AF5-4AC1-B415-1CF51C6798FC

Q28397434-860EF317-75DF-4C26-B327-74DA227D6CD7

Q28397434-C803E9CD-8DF9-491E-8F0E-1D8DECCA000D

Q28397434-F60006F5-C950-4ACC-898B-914FBF61D60A

P577

Q28397434-11E4EF6F-E29B-46E2-B5DA-750FAE00A1FB

P698

Q28397434-CB1C59EB-1427-453A-9B36-07921A14878E

P932

Q28397434-18F75428-E205-4380-971C-B98B638E2566

P3181

P356

J.ATHEROSCLEROSIS.2013.01.034

P1433

Atherosclerosis

P1476

Cytochrome P450-derived eicosa ...... ronary artery disease patients

@en

P2093

Alan L Hinderliter

http://www.w3.org/2001/XMLSchema#string

Almasa Bass

http://www.w3.org/2001/XMLSchema#string

Bryant Tran

http://www.w3.org/2001/XMLSchema#string

Fred B Lih

http://www.w3.org/2001/XMLSchema#string

George A Stouffer

http://www.w3.org/2001/XMLSchema#string

Kenneth B Tomer

http://www.w3.org/2001/XMLSchema#string

Kyle Ellis

http://www.w3.org/2001/XMLSchema#string

Melissa Caughey

http://www.w3.org/2001/XMLSchema#string

Robert N Schuck

http://www.w3.org/2001/XMLSchema#string

Savanna Steele

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study

A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure

Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease

Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins

Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans

Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice

Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation

Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation

P304

442-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3521376

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.ATHEROSCLEROSIS.2013.01.034

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

227

http://www.w3.org/2001/XMLSchema#string

P50

Darryl C Zeldin

Brian P Simmons

Katherine N Theken

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23466098

http://www.w3.org/2001/XMLSchema#string

P932

3638946

http://www.w3.org/2001/XMLSchema#string